These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4673711)

  • 1. Immuno-reactive material to bovine TSH in plasma from patients with thyroid cancer.
    Greenspan FS; Lowenstein JM; West MN; Okerlund MD
    J Clin Endocrinol Metab; 1972 Dec; 35(6):795-8. PubMed ID: 4673711
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum thyrotropin (TSH) levels after thyroid ablation compared with TSH levels after exogenous bovine TSH: implications for 131-I treatment of thyroid carcinoma.
    Hershman JM; Edwards CL
    J Clin Endocrinol Metab; 1972 May; 34(5):814-8. PubMed ID: 5062451
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyrotropin releasing hormone (TRH) studies in patients with thyroid cancer.
    Samaan NA; Beceiro JR; Hill CS; Haynie TP; Glenn HJ
    J Clin Endocrinol Metab; 1972 Sep; 35(3):438-43. PubMed ID: 4626272
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma immunoreactive TSH: spurious elevation due to antibodies to bovine TSH which cross-react with human TSH.
    Frohman LA; Baron MA; Schneider AB
    Metabolism; 1982 Aug; 31(8):834-40. PubMed ID: 6808295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioimunologic doseof thyrotropin hormoe. Preliinary resul].
    Vigneri R; Papalia D; Squatrito S; Mottl
    Folia Endocrinol; 1970 Jun; 23(3):314-30. PubMed ID: 5537352
    [No Abstract]   [Full Text] [Related]  

  • 7. [Radioimmunoassay of TSH by double antibody method].
    Hiroshige N; Kanao K; Yagi A; Honda M; Sakota M
    Horumon To Rinsho; 1971 Apr; 19(4):299-304. PubMed ID: 5165111
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum thyroglobulin in thyroid cancer and other thyroid diseases].
    Demidchik EP; Kruglova NE; Minaĭlo TI; Gauptman AE; Koren' TA; Gedrevich ZE; Sevkovskiĭ IaI
    Lab Delo; 1990; (7):16-8. PubMed ID: 1699058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyroid and calcitropic hormone secretion disorders in thyroid cancer].
    Ivanov PK; Telish VM
    Med Radiol (Mosk); 1983 Aug; 28(8):51-4. PubMed ID: 6888211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular immunologic parameters in thyroid diseases].
    Beyer PA; Wenisch HJ; Schumm-Draeger PM; Hanisch E; Seufert RM; Encke A
    Acta Med Austriaca; 1989; 16(1):6-7. PubMed ID: 2785324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA and thyroid carcinoma.
    Ahuja S; Hoppe I; von Keyserlingk H; Ernst H
    Exp Clin Endocrinol; 1992; 99(3):134-6. PubMed ID: 1526261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radioimmunoassay for human plasma thyrotropin and its application in thyroid disease.
    Lemarchand-Béraud T
    J Nucl Biol Med; 1969; 13(1):14-25. PubMed ID: 5393665
    [No Abstract]   [Full Text] [Related]  

  • 13. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
    Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
    Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly sensitive determination of TSH in the follow-up of TSH-suppressive therapy of patients with differentiated thyroid cancer.
    Mann K; Saller B; Mehl U; Hörmann R; Moser E
    Nuklearmedizin; 1988 Feb; 27(1):24-8. PubMed ID: 3368333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falsely positive bovine TSH radioimmunoassay responses in sera from patients with thyroid cancer.
    Greenspan FS; Lew W; Okerlund MD; Lowenstein JM
    J Clin Endocrinol Metab; 1974 Jun; 38(6):1121-2. PubMed ID: 4831705
    [No Abstract]   [Full Text] [Related]  

  • 16. [Iodine deficiency induces thyroid cancer in rats and mice].
    Fang WT; Qao BS; Wang JB
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):341-4. PubMed ID: 7895583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case with thyroid carcinoma associated with falsely increased TSH values].
    Kobayashi K; Maeta H; Honda T; Tanaka Y; Mori T
    Nihon Geka Gakkai Zasshi; 1997 Jan; 98(1):68-70. PubMed ID: 9046521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histological and immuno-morphological characteristics of differentiated cancer of the thyroid gland].
    Shevchenko SI; Iakimova TP; Shevchenko RS
    Sov Med; 1991; (4):19-21. PubMed ID: 1871617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of HLA with thyroid cancer. An effect of iodine sufficiency and safe environment?
    Larsen B; Thompson C; Kwan A; Farid NR
    Tissue Antigens; 1986 Nov; 28(5):298-300. PubMed ID: 3824363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer.
    Iorcansky S; Herzovich V; Qualey RR; Tuttle RM
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6553-5. PubMed ID: 16174712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.